AGOMAB THERAPEUTICS NV
Institutional coverage
28 13F filers hold $AGMB.
13F holders
28
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
2 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 28 · Source: 13F-HR01
Adamsbrown Wealth Consultants LLC
5.28% of portfolio
5,141,992 sh
02
Vida Ventures Advisors, LLC
0.62% of portfolio
4,106,466 sh
03
Marquard & Bahls AG
1.24% of portfolio
3,100,000 sh
04
Capital Counsel LLC
8.69% of portfolio
2,783,096 sh
05
Nomura Asset Management Co. Ltd.
0.03% of portfolio
1,618,000 sh
06
TB Capital Gestao de Recursos Ltda.
—
1,340,452 sh
07
Wallace Capital Management Inc.
0.47% of portfolio
1,200,000 sh
08
CFO4Life Group, LLC
0.01% of portfolio
707,656 sh
09
Castleview Partners, LLC
0.61% of portfolio
600,000 sh
10
Oarsman Capital, Inc.
0.01% of portfolio
500,000 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $AGMB in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $AGMB in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:35 UTC.